RPL39P9: A Drug Target / Disease Biomarker (G100270894)

Target Name: RPL39P9

NCBI ID: G100270894

RPL39P9

Other Name(s): ribosomal protein L39 pseudogene 9 | RPL39_4_77 | Ribosomal protein L39 pseudogene 9

RPL39P9: A Drug Target / Disease Biomarker

RPL39P9 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the P9 family of proteins, which are known for their role in regulating protein synthesis and post-translational modification (PTM) in cells.

One of the unique features of RPL39P9 is its ability to interact with various drug compounds, making it an attractive target for drug development. The protein is known to be highly responsive to small molecules, including inhibitors such as Chemicals, UV and radiation, as well as some antibiotics. This responsiveness has led to the identification of RPL39P9 as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, RPL39P9 has also been shown to be a valuable biomarker for several diseases. The protein is expressed in various tissues and has been shown to be involved in a number of cellular processes, including cell signaling, protein synthesis, and cellular organization. This makes it a potential source of diagnostic information in diseases that affect these processes, such as cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key advantages of RPL39P9 as a drug target is its relatively simple structure. The protein has only four known functions, all of which involve the regulation of protein synthesis and post-translational modification. This makes it relatively easy to identify and modify, which is important for drug development. Additionally, the protein has a relatively low potential for toxicity, which is important for its use in humans.

In addition to its potential as a drug target and biomarker, RPL39P9 has also been shown to play a role in several cellular processes that are important for human health. For example, the protein has been shown to be involved in the regulation of cell signaling, which is important for the development and maintenance of tissues and organs. Additionally, the protein has been shown to be involved in the regulation of protein synthesis and post-translational modification, which are important for the development and maintenance of proteins that are essential for human health.

Overall, RPL39P9 is a protein that has great potential as a drug target and biomarker. Its relatively simple structure, low potential for toxicity, and involvement in important cellular processes make it an attractive target for drug development. Additionally, its potential as a biomarker for diseases that affect protein synthesis and post-translational modification gives it hope as a diagnostic tool in the future.

Protein Name: Ribosomal Protein L39 Pseudogene 9

The "RPL39P9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL39P9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets